General Information of Drug (ID: DM601GL)

Drug Name
INNO-105 Drug Info
Synonyms Opioid growth factor (cancer), Innovive/Penn State; (MEt5)-enkephalin (cancer), Innovive/Penn State
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
443363
TTD Drug ID
DM601GL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Opioid receptor zeta (OGFR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
IRT-102 DMCAFVN Pancreatic cancer 2C10 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Opioid receptor zeta (OGFR) TT6IEYX OGFR_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT00255333) INNO-105 in Patients With Solid Tumors. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 428488).
3 The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide. Eur J Pharmacol. 1978 Feb 1;47(3):319-31.